缺陷药品的侵权责任主体  

Discussing the subject of defective drug tort liability

作　　者：张建平[1] 

机构地区：[1]浙江医药高等专科学校,浙江宁波315100

出　　处：《中国卫生事业管理》2013年第12期915-918,共4页Chinese Health Service Management

基　　金：浙江省哲学社会科学规划课题"缺陷药品侵权的救济问题研究"(编号:11XKGJ10)

摘　　要：目的:分析缺陷药品侵权的责任主体。方法:采用比较研究方法、文献研究方法。结果与结论:缺陷药品的侵权责任主体,包括药品的生产者、销售者、进口者、医疗机构,以及国家责任问题。药品生产企业,是缺陷药品的第一责任人,其身份的确定可适用市场份额责任理论和共同危险行为理论。药品零售企业,会面临产品责任和药学服务事故责任的混合。医疗机构,针对一般药品和医疗机构制剂的区别,会分别承担销售者责任和生产者责任。缺陷药品所涉不当行政行为,目前无法获得国家赔偿。Objective To study the subject of defective drug tort liability. Methods Literature research and comparative study method were applied. Results and Conclusion The subjects of defective drug tort liability are drug manufacturers, sellers, import- ers, medical institutions and state compensation. Drug manufacturer is the first liability subject, who can be confirmed by market share liability theory and common risk behavior theory. Drug retail enterprises will encounter product liability mixed with pharmaceutical care liability. Medical institutions will respectively undertake liability as sellers for general drugs, or liability as manufacturers for their preparations. Improper administrative actions on defective drugs couldn＇t obtain state compensation.

关 键 词：药品 缺陷 侵权 产品责任 医疗机构 

分 类 号：R-5[医药卫生]